EBS · Healthcare · $341M
After-hours $6.600.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“2분기 매출 2억3400만 달러로 가이던스 최고치(1억8500만 달러)를 크게 웃돌았고, 이자·세금 등 빼기 전 영업이익률도 41%로 작년 같은”
In the company's words · 2026 2분기 earnings call